Collegium Pharmaceutical (COLL) Assets Average (2015 - 2026)

Collegium Pharmaceutical's Assets Average history runs 12 years deep, the most recent figure standing at $1.7 billion for Q1 2026.

• On a quarterly basis, Assets Average changed 0.42% year-over-year to $1.7 billion in Q1 2026; TTM through Mar 2026 was $1.7 billion, a 0.42% change from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 18.3% from the prior year.
• Assets Average grew to $1.7 billion in Q1 2026 per COLL's latest filing, from $1.6 billion in the prior quarter.
• Across five years, Assets Average topped out at $1.7 billion in Q1 2026 and bottomed at $969.1 million in Q1 2022.
• The 5-year median for Assets Average is $1.2 billion (2022), against an average of $1.3 billion.
• Across the five-year window, Assets Average jumped 83.24% in 2022 and slipped 10.73% in 2024, its largest moves.
• Year by year, Assets Average stood at $1.2 billion in 2022, then declined by 2.28% to $1.2 billion in 2023, then jumped by 42.13% to $1.6 billion in 2024, then retreated by 1.05% to $1.6 billion in 2025, then gained by 1.37% to $1.7 billion in 2026.
• Per Business Quant, the three latest COLL Assets Average figures stand at $1.7 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.6 billion (Q3 2025).